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Abstract
Background: Piscine reovirus (PRV) has been associated with the serious disease known as Heart and Skeletal
Muscle Inflammation (HSMI) in cultured Atlantic salmon Salmo salar in Norway. PRV is also prevalent in wild and
farmed salmon without overt disease manifestations, suggesting multifactorial triggers or PRV variant-specific
factors are required to initiate disease. In this study, we explore the head kidney transcriptome of Sockeye salmon
Oncorhynchus nerka during early PRV infection to identify host responses in the absence of disease in hopes of
elucidating mechanisms by which PRV may directly alter host functions and contribute to the development of
a disease state. We further investigate the role of PRV as a coinfecting agent following superinfection with
infectious hematopoietic necrosis virus (IHNV) – a highly pathogenic rhabdovirus endemic to the west coast of
North America.
Results: Challenge of Sockeye salmon with PRV resulted in high quantities of viral transcripts to become present in
the blood and kidney of infected fish without manifestations of disease. De novo transcriptome assembly of over
2.3 billion paired RNA-seq reads from the head kidneys of 36 fish identified more than 320,000 putative unigenes,
of which less than 20 were suggested to be differentially expressed in response to PRV at either 2 or 3 weeks post
challenge by DESeq2 and edgeR analysis. Of these, only one, Ependymin, was confirmed to be differentially
expressed by qPCR in an expanded sample set. In contrast, IHNV induced substantial transcriptional changes
(differential expression of > 20,000 unigenes) which included transcripts involved in antiviral and inflammatory
response pathways. Prior infection with PRV had no significant effect on host responses to superinfecting IHNV,
nor did host responses initiated by IHNV exposure influence increasing PRV loads.
Conclusions: PRV does not substantially alter the head kidney transcriptome of Sockeye salmon during early (2 to
3 week) infection and dissemination in a period of significant increasing viral load, nor does the presence of PRV
change the host transcriptional response to an IHNV superinfection. Further, concurrent infections of PRV and IHNV
do not appear to significantly influence the infectivity or severity of IHNV associated disease, or conversely, PRV load.
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Background
Piscine orthoreovirus (PRV) is a non-enveloped, double
stranded RNA virus which is a member of the family
Reoviridae [1]. Its genome consists of 10 nucleic acid
segments L1, L2, L3, M1, M2, M3, S1, S2, S3, and S4
that encode for the λ3, λ2/p11, λ1, μ2, μ1, μNS, σ3/p13,
σ2/p8, σNS, and σ1 proteins, respectively [1–3]. PRV
was first identified by pyrosequencing in 2010 as part of
a Norwegian-based study to identify the causative agent
of a recently emerged disease of cultured Atlantic salmon
(Salmo salar) known as Heart and Skeletal Muscle Inflam-
mation (HSMI) [1]. In that study, high levels of PRV
transcripts were found in 28 of 29 diseased specimens, sug-
gesting an association between PRV and HSMI. In Norway,
this association has been strengthened by subsequent chal-
lenge studies and viral screenings from HSMI outbreaks
which have confirmed that PRV is almost always detected
during HSMI [4–8] and host antiviral responses are acti-
vated during this disease [8–11]. However, wild and farmed
Atlantic salmon have also been shown to carry high loads
of PRV in Norway without evidence of HSMI [1, 4, 12].
Shortly after its discovery, PRV was similarly identified
by PCR in farmed Atlantic salmon on the west coast of
North America (Marty and Bidulka, unpublished data).
Subsequent studies have confirmed the presence of PRV
in farmed Atlantic salmon in British Columbia [3, 13, 14],
and also identified PRV in wild salmonids in both BC and
US (Washington and Alaska) waters [3, 14, 15]. Interest-
ingly, although infection with PRV is common in farmed
Atlantic salmon in BC, disease manifestations impacting
fish performance as observed in Norway has never been
reported (reviewed in [16]). Using injection and cohabit-
ation challenge trials, we recently examined the infectivity
and pathogenicity of PRV from the west coast of North
America to Atlantic and Sockeye salmon (Oncorhynchus
nerka) and whether infection would result in HSMI [17].
We demonstrated that PRV was capable of infecting, repli-
cating and persisting within both host species over a
41 week period yet histopathological signs of HSMI were
not observed. As with infections associated with HSMI,
these non-pathogenic infections showed a similar blood cell
tropism and comparable infection dynamics, suggesting
that PRV is of low virulence to Atlantic and Sockeye
salmon in western North America [17].
The pathogenic versus non-pathogenic outcome associ-
ated with PRV infection is puzzling, and suggests multi-
factorial requirements or PRV variant-specific factors may
be required to initiate PRV associated disease. As contrib-
uting factors from the host, pathogen(s), or environment
are unknown with regard to the development of HSMI, it
is important to systematically evaluate PRV pathogenesis
prior to or in the absence of the possibly obfuscating
physiological changes that may occur as a direct result of
this inflammatory pathological state.
In the present study we take advantage of the appar-
ent non-pathogenic relationship which occurs between
PRV and Sockeye salmon in western North America to
identify host-specific transcriptional responses during
early systemic infection and increasing PRV load. We
use next-generation RNA-sequencing (RNA-seq) tech-
nologies in conjunction with contemporary bioinformatics
tools to describe and compare head kidney transcriptomes
of PRV infected and non-infected Sockeye salmon. Guided
by RNA-seq differential expression analyses, we further
explore the significance of selected genes in expanded
biological, tissue and temporal datasets with regard to
PRV-specific host responses.
A second major objective of this study was to deter-
mine whether infection with PRV of no or low patho-
genicity would affect how hosts respond to challenge
with another RNA virus and if such co-infections could
lead to PRV induced pathology; or, conversely, afford
the host with a protective advantage against a superin-
fecting viral pathogen. As PRV has been shown to es-
tablish long-term infections in its hosts [17] and is
common in natural systems along the western cost of
Canada [14], it is inevitable that such co-infections will
(or do) occur. One pathogen that is sympatric with
PRV is infectious hematopoietic necrosis virus (IHNV);
which occurs naturally in the waters of western North
America and can cause acute disease (IHN) in nearly
all salmonid species given appropriate viral, host, and
environmental conditions. In British Columbia, IHNV
predominately infects Sockeye salmon where much of
the viral replication and associated pathology occurs in
the kidney during acute infection [18] – an organ which
also manifests high loads of PRV [7, 17] and has a signifi-
cant proportion of blood associated cells to potentially
indicate both systemic and organ-specific responses. We
thus explore the consequences of a PRV infection on host
cellular functions within the head kidney before and during
superinfection with IHNV in hopes of better understanding
such dynamics as may occur in natural environs.
Methods
Animal source and husbandry
Pitt River Sockeye salmon fry representing 140 families
were obtained from Inch Creek Hatchery, British
Columbia, Canada, and brought to the Pacific Biological
Station (PBS) in Nanaimo, British Columbia, Canada. Fish
were reared in 6 °C (±1 °C) dechlorinated freshwater
under a natural photoperiod for 11 months at which time
they were transitioned to seawater. Fish were reared in
11 °C (±1 °C) sand filtered UV-treated seawater for an
additional 24 weeks prior to challenge. While in fresh-
water the fish were fed daily at 2.8 % body weight dry
pellets (EWOS). Following transfer to seawater the feeding
rate was reduced to 1 % body weight per day. Prior to
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their use in challenge trials a subsample of 20 fish was
screened for the presence of PRV and IHNV using the
methods described below.
PRV intraperitoneal injection challenge
Sockeye salmon post-smolts were challenged with PRV
by intraperitoneal (i.p.) injection following previously de-
scribed methods [7, 17]. Inoculum containing PRV was
prepared from pooled blood homogenates of 20 Atlantic
salmon that had previously been shown to be infectious
[17]. The mean load of reverse-transcribed PRV L1 tran-
scripts in the PRV inoculum was approximately 7.1 × 105
per 100 μL (Ct 20.3). A mock inoculum was prepared
from pooled blood of 20 non-infected Atlantic salmon
and confirmed to be PRV free by real-time quantitative
polymerase chain reaction (qPCR) using methods de-
scribed below. Nine hundred Sockeye salmon (approxi-
mately 40 g each) were i.p. injected with 100 μl of either
PRV inoculum, mock inoculum, or L-15 media (300 fish
per treatment) under 50 mg per L tricaine methanesulfo-
nate (MS222) anaesthesia. Following injection, fish were
assigned to four replicate tanks (75 fish per 360 L tank)
per treatment group and held in 11 °C (±1 °C) sand
filtered UV-treated seawater (32 ppt) in a 5–6 L per min
flow-through system. Samples of blood and head kidney
(approximately 50–100 μL and 50 mg, respectively) were
collected from three fish from each tank (12 per treat-
ment group) at 2, 5, 7 and 14 days post challenge (dpc).
Clinical signs of disease, feeding performance, morbidity,
water temperature, oxygen saturation and salinity were
recorded daily.
IHNV waterborne exposure
Fourteen days following challenge with PRV, half of the
remaining Sockeye salmon (two tanks from each PRV
treatment group) were exposed to an infectious dose of
IHNV (genogroup U; isolate BC93-057) via waterborne
exposure following previous methods [19]. Virus was
propagated on Epithelioma papulosum cyprini (EPC)
cells and brought to a final titre of 1 × 108 plaque form-
ing units (PFU) per mL in Hank’s Balanced Salt Solution
(HBSS). Water flow was stopped and tank volume
reduced to 100 L. Virus was added to a final concentra-
tion of 103 PFU per mL and fish were held in the virus
solution with aeration for one hour after which seawater
flow was resumed and the tanks refilled to 360 L capacity.
The remaining population (two tanks from each PRV
treatment group) were mock challenged using HBSS
under the same experimental conditions.
Four hours after the waterborne exposure, 28 of the 63
fish in each replicated treatment tank were removed and
placed into corresponding 50 L circular tanks supplied
with 1–2 L per min of 11 ° C filtered UV-treated seawater.
Samples of blood and head kidney were collected from a
portion of these fish (n = 4 fish per tank; 12 fish per
treatment) at 1, 3, 7, 21 and 34 days post IHNV chal-
lenge. This corresponded to 15, 18, 21, 34 and 62 dpc
with PRV, respectively. Remaining fish (n = 35) held in
each larger 360 L tank were monitored for 48 days for
clinical signs of disease and morbidity in the absence of
sampling disturbance (Fig. 1a).
In addition to the samples described above, samples of
head kidney and skeletal muscle from all treatment
groups were taken for histopathology at 21 and 62 dpc
PRV (7 and 48 dpc IHNV). Tissues were fixed in 10 %
neutral buffered formalin for 24 h and then transferred
to 70 % ethanol prior to paraffin embedding. The paraffin
embedded samples were cut and stained with hematoxylin
and eosin (H & E) [20] before histopathological evaluation
by light microscopy.
Viral detection and quantification
Blood and head kidney samples were tested for the pres-
ence of PRV by real-time qPCR as previously described
[17]. Briefly, total RNA was extracted in TRIzol Reagent
(Life Technologies) as per manufacturer’s instructions
using 5 mm steel beads and TissueLyser II (Qiagen)
which operated for 2 min at 25 Hz. A portion of eluted
RNA (1.5 μg) was denatured for 1 min at 80 °C and
reverse-transcribed using a High Capacity cDNA Re-
verse Transcription kit (Life Technologies) following the
manufacturer’s instructions. Resulting cDNA was used
directly as template for qPCR analysis in a StepOne-Plus
real-time detection system (Applied Biosystems) using
primers and TaqMan probe targeting the L1 fragment of
the PRV genome (Additional file 1). Each reaction con-
tained 400 nM primers (Eurofins Genomics) and 300
nM TaqMan probe (Life Technologies), 1X TaqMan
Universal Master Mix and 2.5 μL cDNA template in a
total of 25 μL. Cycling conditions included an initial
incubation of 94 °C for 15 min followed by 45 cycles of
94 °C for 15 s, 54 °C for 30 s and 72 °C for 15 s.
The resulting cDNAs were also tested for the presence
of IHNV by qPCR following methods previously described
[21]. Briefly, primers and TaqMan probe targeting the
nucleocapsid (N) gene of IHNV (Additional file 1) were
combined in reactions containing 900 nM of each forward
and reverse primers, 200 nM of IHNV N probe, 1X
TaqMan Universal Master Mix and 2.5 μL cDNA template
in a total of 25 μL. Cycling conditions were 50 °C for
2 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for
15 s and 60 °C for 1 min. Fluorescence was measured at
the end of each cycle on a StepOne-Plus real-time detection
system.
All samples were assayed in duplicate for each virus
and were considered positive if both technical replicates
reported a Ct value < 40 cycles. Absolute quantification
of reverse transcribed viral RNA was determined in each
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Fig. 1 PRV and IHNV challenge of Sockeye salmon. a A schematic diagram presents the experimental design of this study. Circles represent
experimental tanks and roman numerals indicate the number of fish initially added to each respective tank. 1.) 900 Sockeye salmon representing
140 families were acclimated to 12 °C seawater. 2.) Fish were equally divided into three groups and administered 100 μL injections of either:
media control (grey), media/blood homogenate control (blue), or media/blood homogenate containing PRV (orange). 3.) Tissue and blood
samples were collected from three fish in each tank at 2, 5, 7, and 14 days post challenge. 4.) Immediately following 14d sampling, two tanks in
each PRV challenge group were administered a 1 h immersion of either: media control (vertical lines) or media containing IHNV (checkerboard). 5.)
Four hours following immersion, 28 fish from each tank were moved to a smaller corresponding tank. 6.) Tissue and blood samples were
collected from four fish in each of the smaller tanks at 1, 3, 7, 21 and 34 days post immersion. Fish remaining in the larger tanks (n = 35/tank)
were monitored for morbidity without sampling disturbance. (★) indicates the populations and relative timing for samples collected that were
used in RNA-seq transcriptome profiling. b Data presents PRV L1 transcripts per μg total extracted RNA for head kidney and (c) blood samples
collected from fish exposed to PRV by intraperitoneal injection. Samples from fish subsequently exposed to IHNV by immersion that did not
develop detectable IHNV kidney infections (IHNV-) are also distinguished from samples with detectable IHN virus (IHNV+). d Presents IHNV N
transcripts per μg total RNA for head kidney samples where IHNV was detectable by qPCR (n = 19 infected of 120 challenged). Samples from
fish previously exposed and harboring PRV L1 transcripts are distinguished from mock injected controls. The number of PRV challenged IHNV
exposed samples for which IHNV was not detected by qPCR is provided in brackets. e Kaplan-Meier survival curves of fish exposed to PRV,
IHNV, or PRV and IHNV presented in 62 day time course in reference to PRV challenge (n = 105 per treatment group). In all instances, relative
days post challenge to IHNV superinfection is also provided
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instance by serial dilution of a double-stranded DNA
gBLOCK fragment (IDT Technologies) consisting of
sequence targeted by the qPCR primers (probe) of each
virus. A seven-step 10-fold dilution series of the
gBLOCK fragment spanning a dynamic range of 10-107




Thirty-six samples of head kidney from two time points
(14 and 21 dpc PRV) that consisted of eight experimen-
tal conditions (4–6 individuals per condition; Table 1)
were selected for library construction and RNA-seq ana-
lysis. A portion (15 μg) of the total RNA extracted from
these samples was purified using 2 U of DNase I (Life
technologies) at 37 °C for 45 min followed by RNeasy
MinElute Cleanup (Qiagen) as per manufacturer’s in-
structions. RNA quality was visualized on a 1 % bleach
denaturing gel [22] and ensured to have a Bioanalyzer
(Agilent) RNA Integrity Number (RIN) > 7.
Sequencing, de novo library construction and functional
annotation
Library construction, sequencing services and bio-
informatics support was provided by the McGill
University and Génome Québec Innovation Centre,
Montréal, Canada. A total of 36 libraries were generated
from the experimental conditions as given in Table 1.
RNA sequencing was performed using 12 lanes (3 libraries
per lane) of an Illumina® HiSeq 2000 (Illumina Inc.) plat-
form targeting polyadenylated mRNA prepared using a
TruSeq V3 Kit with read lengths of 100 bp. Base calls were
made using the Illumina CASAVA pipeline encoded in
Phred 33. De novo transcriptome assembly was performed
on resulting reads following the pipeline described by
Haas et al. [23] based on the Trinity assembly software
suite [24]. In brief, reads were trimmed using Trimmo-
matic software [25] from the 3’ end with a minimal Phred
score of 30 and a minimum length of 32 bp. A normalized
metric of reads was generated using Trinity normalization
utility and surviving paired reads were assembled using
the Trinity assembler [23]. Trinotate was used to identify
putative coding transcripts and all putative transcripts
were aligned against the UniProt 2013_11 protein data-
base using the blastx program from the NCBI BLAST
family. Annotation was assigned to each longest putative
coding transcript derived from each de Bruijn graph
component (unigene) based on highest blastx score
with an Expect value (E) cut-off < 1e-5. First and second
level Gene Ontology (GO) terms were compared using
WEGO [26] for annotated unigenes with highest se-
quence similarity to other chordates. Gene abundance
estimation for all transcripts was calculated using the
RNA-Seq by Expectation-Maximization (RSEM) method
[27] within the Trinity software framework.
Identification of differentially expressed genes
RSEM quantities calculated during de novo assembly were
used to assess differential unigene expression separately in
both edgeR [28] and DESeq2 [29] Bioconductor software
packages. Expressed non-informative unigenes without at
least 0.5 counts per million mapped reads in at least four
libraries were removed prior to either analysis using
edgeR software. Differential expression was assessed
using edgeR and DESeq2 based on the previously de-
scribed protocols of Anders et al. [30] and Love et al.
[31], respectively, in concert with the user guide infor-
mation provided for each package on the Bioconductor
website. A complete set of R-language commands and the
session information applied in this study are provided for
each analysis (see Additional file 2). Unigenes were con-
sidered differentially expressed at a p value < 0.05 follow-
ing a Benjamini and Hochberg false discovery rate (FDR)
adjustment of 5 % (0.05). To ensure higher stringency for
putative differential regulation, unigenes were only consid-
ered for subsequent comparison and qPCR validated if
they were identified as significant by both edgeR and
DESeq2. Resulting differentially expressed unigenes were
compared between analyses using VENNY [32].
Gene expression by real-time qPCR
Total RNA was extracted from samples of head kidney
and blood as described above. For each sample, 1.5 μg
of DNAse-treated column-purified total RNA was re-
verse transcribed using a High Capacity cDNA Reverse
Transcription Kit (Life Technologies) without RNase
inhibitor following manufacturer’s instructions except
that the random primer mix was substituted with
50 μM Olido d(T)16. Early time point (2 to 14 dpc
PRV) qPCR was performed using a ViiA7 Real-Time
PCR system (Applied Biosystems). PCR amplification
was carried out in triplicate reactions containing Power
SYBR Green master mix (Applied Biosystems), 50 nM
forward and reverse primers (Additional file 1), and
2 μL of cDNA template (diluted 1:10 in water) in
nuclease-free water to a total volume of 13 μL. Cycling
conditions consisted of 50 °C for 2 min then 95 °C for
10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C
for 1 min, with fluorescence measured at the end of each
60 °C step. A portion of pooled cDNA was used to pro-
duce a five-step fourfold dilution series for assessing amp-
lification efficiency and linearity in each run as previously
described [33].
All other real-time qPCR analyses were conducted on
a StepOne-Plus real-time detection system using SYBR
green chemistry. Each PCR reaction consisted of 2X
SYBR mastermix (Life Technologies), forward and reverse
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Table 1 RNA-seq analysis of Sockeye salmon head kidney transcriptomes in response to PRV and IHNV challenge




Library name Accession Raw reads Surviving (%)
Group 1 [6 of 11]
14 dpc PRV Mock injected; PRV- Not challenged S86d14nHK SRX1733826 71,073,165 65,851,201 (93)
S87d14nHK SRX1733827 67,245,066 61,789,431 (92)
S88d14nHK SRX1733828 70,681,709 65,014,139 (92)
S89d14nHK SRX1733829 71,447,579 65,600,555 (92)
S91d14nHK SRX1733830 64,978,759 61,093,604 (94)
S92d14nHK SRX1733831 66,681,946 60,949,173 (91)
Group 2 [6 of 12]
14 dpc PRV PRV injection; PRV+ Not challenged S103d14pHK SRX1733832 69,883,741 64,413,986 (92)
S104d14pHK SRX1733833 72,924,197 68,348,422 (94)
S105d14pHK SRX1733834 74,979,891 69,788,197 (93)
S106d14pHK SRX1733835 73,571,988 68,612,747 (93)
S107d14pHK SRX1733836 68,838,981 64,977,854 (94)
S108d14pHK SRX1733837 60,186,123 57,101,607 (95)
Group 3 [4 of 4]
21 dpc PRV (7 dpc IHNV) Mock injected; PRV- Mock immersion; IHNV- SM928d21nHK SRX1733838 66,335,529 62,802,984 (95)
SM929d21nHK SRX1733839 67,164,004 62,826,291 (94)
SM930d21nHK SRX1733840 82,046,060 77,026,671 (94)
SM931d21nHK SRX1733841 70,537,334 66,494,922 (94)
Group 4 [4 of 8]
21 dpc PRV (7 dpc IHNV) Mock injected; PRV- IHNV immersion; IHNV- S194d21nHK SRX1733842 70,095,033 66,369,408 (95)
S195d21nHK SRX1733843 67,157,595 63,977,824 (95)
S197d21nHK SRX1733844 71,994,014 68,166,660 (95)
S203d21nHK SRX1733845 50,101,150 47,036,872 (94)
Group 5 [4 of 4]
21 dpc PRV (7 dpc IHNV) Mock injected; PRV- IHNV immersion; IHNV+ S193d21nHKIHN SRX1733846 79,273,511 75,681,360 (95)
S199d21nHKIHN SRX1733847 76,263,972 72,360,305 (95)
S200d21nHKIHN SRX1733851 79,506,752 74,578,577 (94)
S201d21nHKIHN SRX1733862 78,032,333 74,005,961 (95)
Group 6 [4 of 4]
21 dpc PRV (7 dpc IHNV) PRV injection; PRV+ Mock immersion; IHNV- SM932d21pHK SRX1733881 67,630,420 64,227,495 (95)
SM933d21pHK SRX1733897 73,000,502 69,415,730 (95)
SM934d21pHK SRX1733920 83,809,559 79,117,126 (94)
SM935d21pHK SRX1733933 64,948,232 61,072,090 (94)
Group 7 [4 of 8]
21 dpc PRV (7 dpc IHNV) PRV injection; PRV+ IHNV immersion; IHNV- S206d21pHK SRX1733942 68,443,344 64,815,041 (95)
S209d21pHK SRX1733943 67,232,098 63,015,730 (94)
S211d21pHK SRX1733944 70,212,619 65,656,348 (94)
S213d21pHK SRX1733945 75,015,092 70,950,399 (95)
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primers (500 nM each; Additional file 1), and 2 μL cDNA
template (diluted 1:5 in water) to a final volume of 20 μL.
Samples were assayed in duplicate with a five-step, four-
fold dilution series of pooled cDNA included in each run
to calculate amplification efficiency and linearity. Cycling
conditions consisted of an initial activation of DNA poly-
merase at 95 °C for 10 min, followed by 40 cycles of 5 s at
95 °C, 25 s at 60 °C, and 10 s at 72 °C. At the end of all
gene expression cycling protocols, melt curve analyses
were run to ensure amplification specificity.
Target gene expression was normalized to the two most
stable of four putative reference genes: elongation factor-1
alpha (EF1-α), beta-actin (β-Actin), acidic ribosomal pro-
tein (ARP) and Dynein (Dyn) as determined by the con-
sensus of geNorm [34], BestKeeper [35],and NormFinder
[36] software. Relative quantities were calculated from the
qPCR raw fluorescence data using the global fitting mech-
anistic model of Carr and Moore [37] within the qpcR R-
statistical software package [38]. Corrected normalized
relative quantities were then compared at each time point
by t-test or one-way ANOVA and Tukey post hoc test
where appropriate using Graphpad Prism 5.0 following
Log10 transformation of the data.
Results
Sockeye salmon were susceptible to PRV by i.p. injection
and developed substantial blood and head kidney infections
Both head kidney and blood of naïve Sockeye salmon
became highly infected with PRV following i.p. injection
(Fig. 1). All fish sampled had detectible systemic levels
of PRV L1 transcripts at 5 dpc. Viral loads in both blood
and head kidney increased to 34 dpc, and then declined
slightly by the end of the challenge (62 dpc PRV)
(Fig. 1b & c). Mean reverse-transcribed PRV L1 tran-
scripts at 34 dpc in blood and head kidney reached
3.2 × 106 and 7.7 × 105 copies per μg total RNA, re-
spectively. These levels corresponded roughly to 2.4 ×
108 mean PRV L1 reverse-transcribed copies recovered
from the combined portions of blood (~33 μg RNA)
and head kidney (~173 μg RNA) sampled. These levels
demonstrate that substantial PRV transcription occurred
following challenge as each fish was initially i.p. challenged
with < 1 × 106 L1 copies of PRV. Levels of PRV in head
kidney tissue used in library construction ranged from
1.1 × 102 to 5.1 × 103 copies per μg total RNA at 14 dpc
and from 3.3 × 103 to 8.8 × 103 copies per μg total RNA at
21 dpc.
In this study i.p. challenge with PRV resulted in no
morbidity or other signs of clinical disease over a
62 day period. In general, the histopathological lesions
were few, mild and unspecific. As no heart tissue was
available for histopathological evaluation, it was not
possible to evaluate if any of the PRV infected fish de-
veloped HSMI. However, kidney and heart samples col-
lected at 21 and 62 dpc revealed very few and mild
lesions. Two fish had sparse, focal myositis in red car-
inal muscle, one fish had degenerative changes in red
mid line muscle and two fish had interfibrillar exud-
ation in red and white muscle, respectively. Samples of
the kidney were without pathological lesions. The
changes observed in the skeletal muscle samples were very
sparse, focal and almost evenly distributed between PRV
challenged and unchallenged fish and do not resemble the
muscle inflammation described for HSMI in Atlantic sal-
mon [39]. A detailed report of the histopathological find-
ings is provided as Additional file 3.
Immersion challenge of IHNV resulted in limited numbers
of Sockeye salmon developing kidney infections
Of those samples collected over the 48 day period post
IHNV challenge only 19/120 (16 %) individuals tested
positive by qPCR for IHNV in the head kidney (Fig. 1d).
Prevalence of IHNV, as well as mean viral load, was
highest at 7 dpc challenge with IHNV, corresponding to
33 % and 2.2 × 107 IHNV N reverse-transcribed tran-
scripts per μg total RNA, respectively. As seen for PRV,
IHNV loads declined in the last samples taken at 48 dpc
with IHNV.
Morbidity ranged from 0 to 11 % in infected tanks
following IHNV exposure and occurred between 13 and
35 dpc (Fig. 1e). Although cumulative IHNV associated
morbidity was highest in the PRV coinfection group (6.5
± 1.7 % SE), this was not significantly different to the
group which received mock PRV injections (1.9 ± 1.2 %
Table 1 RNA-seq analysis of Sockeye salmon head kidney transcriptomes in response to PRV and IHNV challenge (Continued)
Group 8 [4 of 4]
21 dpc PRV (7 dpc IHNV) PRV injection; PRV+ IHNV immersion; IHNV+ S207d21pHKIHN SRX1733946 73,284,580 69,850,430 (95)
S210d21pHKIHN SRX1733947 68,951,128 65,368,893 (95)
S214d21pHKIHN SRX1733948 68,150,625 64,986,061 (95)
S216d21pHKIHN SRX1733949 72,009,581 67,717,231 (94)
Libraries are organized into eight groups respective of unique experimental treatment, time points sampled and kidney infection status by both PRV and IHNV as
assessed by qPCR. Associated libraries, NCBI SRA accession and sequencing coverage are provided in each instance. The numbers in brackets next to the group
identifications indicate the number of samples screened by RNA-seq out of the total number of collected experimental samples available for that condition
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SE) (Additional file 4). The most common histopatho-
logical finding in kidney samples was mild circulatory
disturbances in the interstitial tissue (5 fish). In head
kidney, one fish had hematopoietic tissue with multifocal
pyknotic and karyorrhectic nuclei, and another fish had
few, small foci of interstitial haemorrhages. Some fish
had signs of degenerative or necrotic changes in the epi-
thelium of a few tubuli. The finding of necrotic cells and
pyknotic, karyorrhectic cells in haematopoietic tissue of
the kidney in two IHNV challenged fish is probably a
typical manifestation of IHN [40].
In muscle samples, the most abundant changes ob-
served were degeneration of white and/or red muscle,
sometimes combined with increased eosinophilia of
the fibers, but without inflammatory responses to the
changes. Also in this group, some muscle samples dis-
played what appeared to be exudation between red
and/or white muscle, and a few specimens had a char-
acteristic clear vacuolation of red muscle fibers. Few
individuals had slight interfibrillar hypercellularity of
red muscle, and one fish had a focal, very sparse myo-
sitis in red muscle. The vacuolization of red muscle fi-
bers and interfibrillar muscular exudation could result
from damaged vessels, not uncommon in IHN diseased
fish, but the number and occurrence of this also in fish
challenged with PRV only suggest that the observed
changes are more likely to represent some kind of
metabolic or physiologic imbalance.
IHNV and PRV infection dynamics were unaltered during
periods of coinfection
Neither exposure or acute superinfection with IHNV
significantly altered the transcription of PRV L1 tran-
scripts in Sockeye salmon head kidney or blood (Fig. 1b
& c). In addition, the presence of PRV did not signifi-
cantly affect IHNV loads (Fig. 1d) or the outcome of
IHNV challenge with respect to prevalence of infection
and morbidity (Fig. 1d & e). A complete sample inven-
tory including viral load estimates and morbidity are
provided in Additional file 4. The histopathologic find-
ings in muscle samples from fish challenged with both
PRV and IHNV are relatively similar to what was seen
in fish challenged with IHNV only. In kidney, circula-
tory disturbances in the haematopoietic kidney tissue
and degenerative changes to tubuli epithelium are the
most common findings. A majority of the fish with
degeneration of red and/or white muscle, the most
abundant muscle change found (19 fish), were from fish
challenged with IHNV, or IHNV and PRV, and these
findings could be associated with one or both viral infec-
tions. However, the specimens for histopathological evalu-
ation were in general of small size with less amount of
relevant tissue than ideal for detecting lesions related to
PRV or IHN, resulting in many samples with artefacts that
could obscure the interpretation of potentially disease spe-
cific and other pathological changes.
A head kidney reference transcriptome for Sockeye salmon
was created from more than 2.3 billion RNA-seq reads
RNA-seq libraries were generated for 36 samples of
Sockeye salmon head kidney from eight discrete treatment
conditions (Table 1). Surviving paired reads greater than
32 bp following trimming ranged from 47 to 80 million per
library which represented 91-95 % of the raw sequence
reads (Table 1). All libraries have been deposited in the
NCBI Sequence Read Archive, study SRP0740078. Individ-
ual SRA library accession numbers are provided in Table 1.
To support the de novo assembly of our RNA-seq data,
we used the Trinity normalization utility in order to re-
duce memory requirements needed for assembly. Follow-
ing normalization this resulted in 40,403,129 surviving
paired reads from which the reference transcriptome was
assembled. De novo assembly yielded a total of 501,829
unique putative transcripts (Additional file 5) with a total
length of all transcripts of 456,755,195 (bp), an average
transcript length of 901 (bp), a median transcript length
464 (bp) and a maximum transcript length of 17,772 (bp).
These transcripts represent 326,410 unigenes; of
which, approximately 15 % (47,429) were suggested as
being protein-coding following Trinotate and UniProt
bastx annotation analysis (Additional file 6). However,
this is likely a conservative estimate, as blastx predic-
tions using current or future protein databases which
include more annotated genes from Sockeye or other
closely related species may identify additional protein-
coding genes missed during our current analyses.
Further, we set a minimum open reading frame thresh-
old of 100 bp during Transdecoder protein prediction
analysis, thereby excluding unigenes which may only
code for shorter peptides.
Gene ontology classification of putative protein-coding
unigenes which had high association to Eukaryotic Chor-
dates (38,191) revealed 11, 16 and 23 functional groups
classified as either cellular component, molecular func-
tion, or biological process, respectively (Fig. 2). Abun-
dance estimates (RSEM counts) for all unigene associated
transcripts identified in each RNA-seq library is provided
in Additional file 7.
In addition to predictive chordate associated protein-
coding genes, 1240 unigenes showed highest blastx
similarity to non-chordate and presumably parasitic or
commensal organisms. Specifically, 144 putative viral
genes were identified. Although the majority (117) cor-
responded to the Retroviridae family (Additional file 6),
seven IHNV associated genes were identified. These
genes code for the G, N, M, P, and L (three variants) viral
proteins and were present in eight of the IHNV challenged
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libraries: S193d21nHKIHN, S199d21nHKIHN, S200d21n
HKIHN, S201d21nHKIHN, S213d21pHK, S207d21pHK
IHN, S214d21pHKIHN and S216d21pHKIHN. This cor-
responded to seven of the eight libraries identified by
qPCR to have N transcripts as well as one of the eight
IHNV exposed libraries for which qPCR screening did not
detect viral N transcripts (S213d21pHK). A low number
of counts (<200 for all five transcripts) were observed in
all libraries except S199d21nHKIHN, where counts
ranged from 7651 to 53,792 for all five viral transcripts
identified. In general, RNA-seq counts for IHNV followed
the same pattern of estimated copies identified by qPCR.
No PRV-specific transcripts were detected in any RNA-
seq generated libraries; however, this was not unexpected,
as reoviral transcripts have been shown to lack the 3’ poly-
adenylation sequence used during the RNA-seq cDNA
synthesis in this study [41].
Global expression of RNA-seq libraries showed respon-
siveness to IHNV but not PRV infection
Prior to assessing differential gene expression between
treatments we examined overall similarity in global
expression between transcriptome libraries independent
of treatment condition. To reduce complex multidimen-
sional RESM count data into two dimensions of vari-
ation for effective visualization, we used the clustering
algorithms of multidimensional scaling (MDA) and prin-
cipal component analysis (PCA) in edgeR or DESeq2,
respectively.
In both of these analysis, 4/4 individuals from Group 5
(21 day mock PRV injected, 7 day IHNV kidney in-
fected) and 3/4 individuals from Group 8 (21 day PRV
injected, 7 day IHNV kidney infected) orientated separ-
ately from individuals in the other groups which did not
develop detectable IHNV kidney infections (Fig. 3a & b).
Fig. 2 Trinity assembled component (unigene) summary for Sockeye salmon head kidney reference transcriptome. a Putative unigenes identified
by Trinity in de novo assembly from 36 discrete head kidney libraries were determined to be either non- or protein-coding base on Transdecoder
analysis and/or UniProt annotation. b All putative protein-coding unigenes are delineated by their best blastx hit in the UniProt 2013_11 database.
c Unigenes with blast hits associated with Eukaryotic Chordates are categorized by first and second level gene ontology classifiers
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Indeed, IHNV infections contributed strongly to the sec-
ond highest source of variance (Y-axis) in both of these
analyses. Although one individual from Group 8 was a
non-responder (library S210d21pHKIHN), this library
had the lowest quantity of detectable IHNV N tran-
scripts in these groups as identified by qPCR (760 copies
per μg total RNA) and was the only library in either
Group 5 or 8 where IHNV transcripts were not identi-
fied by RNA-seq. Individuals in Groups 4 (21 day mock
PRV injected, 7 day IHNV exposed) and 7 (21 day PRV
injected, 7 day IHNV exposed), although challenged but
without detectable IHNV kidney infections, had a
slightly different ordination when compared to Groups
1, 2 and 3 and 6 which were never exposed to IHNV. In-
fection with PRV did not contribute to consistent library
orientation and was uninformative in its overall effect on
global expression by either MDA or PCA.
PRV induced minor differential unigene expression
changes relative to exposure or infection with IHNV in
Sockeye head kidney
We compared the transcriptional response between
mock and PRV challenged Sockeye salmon head kidneys
at 14 (Group 1 vs. 2) and 21 (Group 3 vs. 6) dpc. At
these time points PRV load in both the kidney and blood
was increasing (Fig. 1b & c). Analyses conducted using
DESeq2 or edgeR on RNA-seq count data revealed 250
and 23 differentially expressed unigenes (DEGs) with
putative responsiveness to PRV, respectively (Fig. 4a).
Higher numbers of DEGs were identified at 14 dpc
when compared to 21 dpc in both analyses; however,
none of the unigenes identified as differentially
expressed at 14 dpc were shared with those identified
at 21 dpc. With respect to the 250 DEGs identified by
DESeq2, many appeared to be non-protein coding. Of
the protein encoding genes, few appeared directly re-
lated to known antiviral pathways and normalized
counts tended to be highly variable between individuals.
When we considered only those genes which were
shared between both DESeq2 and edgeR analyses 17
DEGs were identified. This represented 0.03 % out of
the 60,421 pre-filtered unigene dataset used for each
analysis. Of these, most (13) appeared to be non-
protein coding (Table 2). The protein encoding genes
had blastx annotations as Laminin subunit beta-1 and
Nebulin at 14 dpc, and Ependymin and 18 s rRNA at
21 dpc.
The low number of genes that were responsive to PRV
infection was in strong contrast to the well-developed
transcriptional responses seen following challenge with
IHNV. At 7 dpc IHNV, there was as yet no morbidity as a
result of IHNV; however, the highest prevalence and
abundance of IHNV transcripts was observed at this time
point in both PRV blood injected (4/12; mean 1.3 ± 0.9
SE × 105 copies per μg RNA) and PRV- blood injected (4/
12; mean 4.3 ± 4.2 SE × 107 copies per μg RNA) challenged
Fig. 3 Similarities in global expression between RNA-seq libraries. Two-dimensional variance in global unigene expression of RNA-seq Sockeye
salmon head-kidney libraries (n = 36) visualized by (a) multidimensional scaling analysis following edgeR normalization, or (b) principal component
analysis following DESeq2 normalization and regularized-logarithm transformation. In each instance, collection relative to dpc PRV, exposure to PRV
and/or IHNV, and IHNV kidney infection status (+/−) following challenge are indicated. For detailed experimental group conditions see Table 1
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groups (Fig. 1). The number of putative DEGs that were
common to both DESeq2 and edgeR analysis in response
to IHNV exposure or kidney infection was 25,294 (42 %
prefiltered dataset) and 19,636 (32 % prefiltered dataset),
respectively, (Fig. 4b). For the purpose of this manuscript,
we give only brief focus to these differential comparisons,
which encompass Group 3 (mock) versus 4 (IHNV chal-
lenged but without qPCR detectable kidney infections)
and Group 3 verses 5 (IHNV challenged with detectable
kidney infections). A more complete analysis of the IHNV
responsiveness of this transcriptome is to follow in a sep-
arate manuscript.
Prior infection with PRV appeared to have a negligible
effect on the transcriptional response of head kidney fol-
lowing exposure or infection with IHNV. Only two DEGs
specific to PRV/IHNV coinfection were identified by com-
bined edgeR and DESeq2 analysis (Fig. 4c; Table 2).
qPCR confirmed elevated transcription of Ependymin and
not classic antiviral or inflammatory genes during early
PRV infection
Of the 19 RNA-seq unigenes identified with putative PRV
responsiveness (Table 2), we selected four of the six uni-
genes with protein-coding annotation for qPCR validation:
Nebulin (Nebu) at 14 dpc PRV, Ependymin (Epd) at 21
dpc PRV, and Matrix Metalloproteinase-19 (MMP-19)
and Histidine Ammonia-lyase (HAL) at 21 dpc PRV/7 dpc
IHNV. Expression of these genes by qPCR in reference to
two stable housekeeping genes (βactin and EF1α) showed
that Epd had significant differential regulation in response
to PRV at 21 dpc. This validation was further confirmed in
an expanded sample set which included an additional four
L-15 mock infected controls (Fig. 5). Differential regula-
tion of the other three selected genes was not supported
by qPCR in either the original or an expanded sample set.
Fig. 4 Differential unigenes expression in response to viral infections. Venn diagrams present the number of discrete and shared differentially
expressed (both up and down regulated; 0.05 FDR-adjusted p < 0.05) unigenes identified by either DESeq2 (left), edgeR (right), or those common
(central) to both analyses. Analyses were conducted using a reference transcriptome containing only genes with >0.5 cpm present in at least four
libraries. Treatment-specific comparisons are presented as related to (a) PRV infection, (b) IHNV exposure and/or infection, or (c) those specific to
PRV and IHNV co-infection. In each instance, collection relative to dpc PRV, challenge relative to PRV and/or IHNV, and IHNV kidney infection status
(+/−) following exposure are indicated along with the experimental condition group number (see Table 1)
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In addition, we further confirmed the apparent lack
of antiviral or inflammatory responses to infection
with PRV by examining the gene expression of three
immune-associated proteins: the classical interferon
viral response protein Myxovirus resistence protein 1
(Mx), the inflammatory cytokine Interleukin 1β (IL-1β),
and the inflammatory chemokine Interleukin 8 (IL-8) at
21 dpc PRV. There was no significant difference in the
expression of these genes in response to PRV infection
alone (Groups 3 and 6) or when PRV infected fish were
exposed but not infected with IHNV (Groups 4 and 7)
(Fig. 6). There was a high level of variability in expres-
sion of all three genes in fish that were infected with
IHNV regardless of their PRV infection status. When
compared to Groups 3, 4, 6 and 7, there was signifi-
cantly higher expression of Mx in IHNV infected Sock-
eye (Groups 5 and 8) regardless of PRV infection
status, whereas the expression of IL-1β and IL-8 was
not significantly different as a result of IHNV exposure
and appeared more responsive to those kidney samples
with detectable IHNV infections.
During a preliminary DEG analysis, we used DESeq
(older version) rather than DESeq2 in conjunction with
edgeR to screen unigenes without low-count filtration.
This resulted in an alternate set of putative PRV re-
sponsive DEGs than those subsequently identified by
DESeq2 and edgeR using the prefiltered unigene data-
set presented above. Specifically, this preliminary ana-
lysis identified 14 and 67 DEGs at 14 and 21 dpc PRV,
respectively (Additional file 8). No DEGs were shared
between 14 and 21 day time points in this preliminary
analysis, and only two unigenes were common to both
the preliminary and final analyses: Nebu and Epd, for
which only Epd was validated by qPCR (Fig. 5). Never-
theless, nine additional unigenes of potential immune
relevance were also screened by qPCR in an expanded
early time point sample set (2–14 dpc PRV). Of these,
three genes were identified with putative PRV respon-
siveness for at least one time point, although all were
below a twofold variation from mock injected controls
and were not pursued further in this study (Additional
file 8). A fourth gene, cluster of differentiation-2 (CD2),
Table 2 Putative PRV responsive unigenes
edgeR DESeq2
Analysis Unigene ID Log2FC p value Log2FC p value blastx annotation
Group 1 vs 2 (14d mock vs PRV)
c197414_g1 0.9 0.0234 0.9 0.0002
c196659_g6 1.3 0.0456 1.2 0.0041
c194077_g5 1.7 0.0456 1.5 0.0112
c202007_g10 1.7 0.0456 1.5 0.0128
c191412_g1 1.7 0.0456 1.7 0.0106
c164000_g2 2.1 0.0260 1.8 0.0061
c191921_g6 8.0 0.0300 2.0 0.0480 Laminin subunit beta-1
c189417_g6 2.4 0.0212 2.0 0.0106
c195179_g3 2.4 0.0006 2.1 0.0002
c192081_g1 2.4 0.0002 2.1 0.0001 Nebulin
c190995_g6 2.8 0.0429 2.1 0.0141
c163909_g1 2.6 0.0104 2.2 0.0047
c191538_g2 3.1 0.0104 2.3 0.0051
c181963_g1 3.4 0.0212 2.5 0.0051
c197496_g5 4.0 0.0000 3.2 0.0000
Group 3 vs 6 (21d mock vs PRV)
c162029_g1 3.0 0.0057 2.3 0.0030 Ependymin
c198536_g3 3.9 0.0024 2.9 0.0003 18 s rRNA
Group 5 vs 8 (21d IHNV+ vs PRV/IHNV+)
c193589_g1 −2.8 0.0238 −2.3 0.0041 Matrix metalloproteinase-19
c188458_g3 3.2 0.0238 2.5 0.0033 Histidine ammonia-lyase
Head kidney unigenes identified by both edgeR and DESeq2 as being differentially expressed in response to PRV. For each unigene, the Log2 fold change and
0.05 FDR adjusted p-value are presented as calculated by either edgeR or DESeq2 software packages. Best UniProt annotation (blastx E value < 1e-5) is provided
where available
Polinski et al. BMC Genomics  (2016) 17:848 Page 12 of 22
Fig. 5 Comparative RNA-seq and qPCR calculated expression of PRV responsive genes. For each select PRV responsive unigene, DESeq2 normalized
counts (left) are presented alongside relative quantities assessed by qPCR from the same samples used to prepare RNA-seq libraries (middle) or with
additional samples not incorporated into RNA-seq analysis where available (right) normalized to two stable reference genes. Samples not included in
RNA-seq but with identical condition-specific parameters are indicated (black border). For groups which received mock PRV injections, samples which
received L-15 media injections (open circles) are distinguished from those which received blood homogenate injections (filled circles). Significant
differential expression between experimental groups are indicated at p < 0.05 (*), 0.01 (**) and 0.001 (***) by t-test or at p < 0.05 by ANOVA
with post hoc Tukey test where appropriate. Group 1: mock; Group 2: PRV; Group 3: mock; Group 4: IHNV exposed qPCR-; Group 5: IHNV
exposed qPCR+; Group 6: PRV; Group 7: PRV/IHNV exposed qPCR-; Group 8: PRV/IHNV exposed qPCR+ (Table 1)
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also showed potential PRV responsiveness at 21 dpc as
it was not observed to be expressed in any of the four
PRV challenged kidney samples but was present in
three of the four mock challenged samples. However,
further exploration of CD2 responsiveness to PRV was
not undertaken in this study due to its inconsistent ex-
pression in kidney samples across all temporal treatment
groups (Additional file 8).
Fig. 6 RNA-seq and qPCR expression of select antiviral and inflammatory response genes. DESeq2 normalized counts of three immune response
genes (left) are presented alongside relative quantities for the same samples assessed by qPCR (middle) or with additional samples where
available (right). Samples with identical condition-specific parameters to those tested by RNA-seq are indicated (black border). For groups which
received mock PRV injections, samples which received L-15 media injections (open circles) are distinguished from those which received blood
homogenate injections (filled circles). Significant differential expression between groups is indicated at p < 0.5 by ANOVA and post hoc Tukey
test. Group 3: mock; Group 4: IHNV exposed qPCR-; Group 5: IHNV exposed qPCR+; Group 6: PRV; Group 7: PRV/IHNV exposed qPCR-; Group 8:
PRV/IHNV exposed qPCR+ (Table 1)
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Ependymin expression was confined to early PRV
infection in kidney but not blood and was followed by a
later antiviral response
Quantitative PCR confirmed elevated Epd transcription
but not Mx at 21 dpc PRV. Nevertheless, we further
examined the transcription of these genes at both earlier
and later time points in an attempt to better understand
the temporal significance of their transcription (Fig. 7a).
This identified that increased expression of Epd was only
observed at the 21 dpc sampling time point. The expres-
sion of Mx during PRV infection remained comparable
to mock infected controls for sampling time points out
to 21 dpc; a period marked by significant increases in
systemic viral transcripts representing the major period
of dissemination which we designate as the early phase
of infection. However, at 34 dpc PRV an approximate
eleven-fold increase in Mx was observed in PRV infected
individuals (Fig. 7a). This time point corresponds to the
highest levels of PRV L1 transcripts noted in this study
which we believe represents a mature phase of viral
infection, although it should be noted that a period of
4 weeks elapsed between this and the subsequent
sampling event which obscures precise resolution for the
timing of the peak in viral loads. Nevertheless, the
elevated expression of both these genes was observed to
be transient during persistent PRV infection as neither
Epd nor Mx was differentially expressed at the termin-
ation of the 62 day PRV challenge.
To identify if PRV associated Epd expression was blood
or kidney specific, we further attempted to evaluate Epd
expression by qPCR in peripheral blood of sampled fish
used to demonstrate kidney expression. No amplification
occurred in 35–40 cycles of qPRC in either PRV infected
or non-infected blood cell populations (data not shown).
Additional qPCR analysis of tissues from six non-PRV
infected individuals revealed that Epd was constitutively
expressed in the kidney, heart and skeletal muscle of
Sockeye salmon but not in peripheral blood (Fig. 7b).
Discussion
Sockeye salmon have previously been shown to develop
considerable blood and kidney infections following
cohabitation with PRV infected Atlantic salmon [17]. Here
we confirm that Sockeye develop similar infections
following i.p. injection of PRV prepared from infected
Atlantic salmon blood. As with previous work, no weight
loss, morbidity or pathology could be attributed to the
presence of PRV in Sockeye during this study. These
results supports a growing body of evidence that PRV is
infectious but non-pathogenic to Pacific salmon in
western North America [13, 14, 17]. Nevertheless, even
in Norway where PRV has been associated with disease
in Atlantic salmon, the widespread prevalence of virus in
non-diseased fish, sometimes at high viral load [5, 12]
indicates that much is still unknown with regard to
PRV pathogenicity; particularly concerning mechanisms
involved for inducing pathology.
In this study, we used RNA-seq technologies to
develop a reference transcriptome for Sockeye salmon
head kidney. The Trinity de novo assembly platform
used here has been shown to resolve closely paralogous
genes and polymorphic transcripts in a broad range of
organisms [24], including an Atlantic salmon leukocyte
cell line [42], and is currently considered the forerun-
ning tool for vertebrate transcriptome assembly in the
absence of a reference genome [43]. To our knowledge
this is the first RNA-seq transcriptome dataset for Sockeye
salmon, and provides an important genetic reference for
Fig. 7 Expression of Ependymin and Myxovirus resistance protein following PRV challenge. a Mean (± SE) fold change in transcriptional
expression of Ependymin (Epd) and Myxovirus resistance protein (Mx) in PRV infected samples is presented relative to time-matched mock
infected controls at seven discrete time points following PRV injection challenge. The dotted lines represent a minimum fold change (Twofold)
suggestive of biological significance. b Constitutive expression of Epd in proportion to β-actin is provided for head kidney (Hk), blood (Bld), heart
(Hrt), and skeletal muscle (Sm) from PRV and IHNV free Sockeye salmon (n = 6). Visualization of qPCR products for Epd following 35 amplification
cycles from comparable amounts of total extracted RNA (~1.5 μg) is also provided
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this ecologically and economically important Pacific
salmon species. The total number of unigenes identified
here (326,410) is comparable to the number of unigenes
reported from the de novo assembly of a multi-tissue tran-
scriptome of catfish (370,798) [44]; and although a higher
proportion of catfish genes was initially identified as pro-
tein coding relative to Sockeye (25 % vs 15 %), this is likely
due to differences in categorizing isoforms during assem-
bly [24]. Indeed, the number of putative protein coding
genes identified herein (47,429) is consistent with those
identified in the notochord transcriptome (55,775) [45]
and whole-body transcriptomes (41,735-43,654) [46] of
Atlantic salmon using genome guided assembly. Add-
itionally, an all-by-all blastn search of the current Sock-
eye sequences against the latest salmon repeat database
provided by the University of Victoria consortium for
Genomics Research on all Salmon Project (cGRASP;
http://web.uvic.ca/grasp/) revealed at least 33,456 non-
redundant unigenes (Additional file 9). This is higher
than the quantity of unique protein encoding genes
identified within the catfish transcriptome (25,144) [44]
and is consistent with the 4R salmonid-specific whole-
genome duplication [47, 48] (Additional file 9).
We further identify the Sockeye kidney transcriptome
to be highly responsive to the aquatic single-stranded
RNA rhabdovirus IHNV. A large degree of variance in
global gene expression could be attributed to IHNV in-
fection at 7 dpc and more than 20,000 unigenes showed
putative differential expression following exposure to
waterborne virus. This included significant induction of
antiviral (Mx) and inflammatory (IL-1β) associated
genes as assessed by qPCR, which is consistent with
previous observations of IHNV infections of rainbow
trout (Oncorhynchus mykiss) [49], and is suggestive that
both type-I interferon and NF-κB cellular response
pathways are initiated during early IHNV kidney infec-
tion. Nevertheless, most of the global changes in Sock-
eye gene expression caused by IHNV have yet to be
explored and we are currently expanding our investigations
regarding the IHNV responsiveness of this transcriptome.
We intend to provide further details regarding cell signal-
ling pathways and examine the importance of differentially
regulated non-protein encoding transcripts in a subse-
quent manuscript.
In stark contrast to the well-developed responses gen-
erated against IHNV, PRV appeared to cause almost no
kidney-specific gene expression changes in Sockeye at ei-
ther 2 or 3 weeks post challenge (wpc). The 17 putative
PRV-associated DEGs identified in this study account
for only 0.03 % of the unigenes used in the analysis and
none of the genes identified as differentially expressed at
14 dpc were shared with 21 dpc. The majority of DEGs
identified appear to be non-protein encoding and for
those which had blastx annotations (Laminin subunit
beta-1, Nebulin, Ependymin and 18 s rRNA) only
Ependymin has currently been validated by qPCR.
Ependymin is a glycoprotein that was originally discov-
ered in the cerebrospinal fluid of goldfish [50] and is
believed to be involved in learning processes [51] and
behaviour [52]. More recently however, a number of Epd
paralogues have been identified in a variety of other verte-
brate organs, particularly those of fish, although their
functions are largely unknown [53]. Here, we identify that
at least one Epd gene is constitutively expressed in kidney,
heart, and skeletal muscle of Sockeye salmon but not in
peripheral blood (Fig. 7). We also identified this gene to
be the only qPCR-validated differentially expressed protein
coding gene responsive to early PRV infection in head kid-
ney tissues. Interestingly, Epd expression has also been
shown to be upregulated in the liver of Atlantic salmon
following exposure to the bacterial pathogen Aeromonas
salmonicida [54], in the liver of medaka (Oryzias latipes)
exposed to dioxin [55], and in the distal intestine of Atlan-
tic salmon fed camelina-derived feeds [56]; suggesting the
transcriptional regulation of Epn may be involved in im-
munological, inflammatory, or cellular repair responses.
However, as neither immunological, inflammatory, cellular
repair, nor indeed any other transcriptional pathway ap-
peared to correspond to Epn expression in this study its
biological role in response to PRV appears limited.
In a previous PRV challenge study with Atlantic salmon,
we identified only modest and/or questionable increases
(less than fourfold) in gene expression of the classic anti-
viral response protein Mx during early PRV infection fol-
lowing i.p. injection challenge in both blood and kidney
during log-linear viral amplification [17]. Here we confirm
a lack of an Mx transcriptional response during early PRV
infection in Sockeye kidney and further identify a lack of
other antiviral transcriptional responses during this period
of significant increasing viral load. Together, these studies
indicate that PRV is able to evade or block host responses
during primary infection, amplification and hematogenous
dissemination within salmonids of western North America
during non-pathogenic infection.
Interestingly, an absence of host antiviral signalling dur-
ing early systemic PRV infections may not be exclusive to
non-pathogenic conditions. Dahle et al. [9] examined the
transcriptional response of Atlantic salmon erythrocytes
to infection with PRV using samples obtained from a co-
habitation challenge conducted by Finstad et al. [7] which
resulted in a first detection of PRV at 4 wpc and histo-
logical signs of HSMI at 7 wpc when blood PRV loads
were at their maximum. Microarray analysis conducted
on peripheral erythrocyte samples collected at 5 and 7
wpc reported upregulation of a large number of viral
responsive genes and down-regulation of non-immune
related genes in PRV infected groups at both time points;
however, qPCR validation of antiviral genes associated
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with the interferon response (IFN-1α, IRF-1, RIG-1, Mx
and PKR) as well as the immuno-regulatory genes
Interleukin-10 and Suppressor of Cytokine Signaling-1
did not identify significant responsiveness of these
genes at 5 wpc relative to controls. At 7 wpc, when 4/6
fish sampled had histopathological signs of HSMI and
PRV loads were highest, significant induction of these
genes (except PKR) was observed although variability
between individuals appeared high [9].
In our present study, we identified increased Mx ex-
pression in kidney tissues only once peak viral loads
were reached, which in conjunction with the work of
Dahle et al. [9], suggests that an antiviral response
against PRV is initiated late during the mature phase of
PRV infection and can occur in both the presence and
absence of inflammatory associated disease. However,
without disease manifestations, we observed that Mx
transcription was not maintained and returned to a
comparable control level by 9 weeks post challenge
(Fig. 7a). In another study, Johansen et al. [10] examined
the transcriptional response of Atlantic salmon cardiac
tissues during a mature phase of PRV infection over a
period of 5 to 11 wpc which used an injection challenge
of PRV inoculum made from hearts of Atlantic salmon
experiencing HSMI. This work appeared to encompass a
period after peak PRV infections were reached, as de-
creasing quantities of PRV transcripts were identified in
heart tissues from the first sampling at 5 wpc through to
the end of the experiment at 11 wpc when only one out
of five fish tested positive for PRV. Histopathological
signs of HSMI were first evident at 6 wpc (1/6 fish), be-
came prevalent at 7 wpc (6/6 fish), then declined at the
end of the 11 week trial (2/6 fish). However, even though
PRV loads were in decline and many heart tissues ap-
peared to be in the process of clearing PRV infection,
expression of viral responsive DEGs was reported to be
consistently elevated in challenged heart tissues relative
to time-0 controls throughout this period. Although dif-
ferent tissues make direct comparisons difficult, these
results provide counterpoint to the brief antiviral re-
sponsiveness of Sockeye kidney to PRV in the absence of
disease, and suggest that HSMI may perpetuate antiviral
signalling as a direct result of pathology in infected
tissues.
Currently, the only study that has observed significant
host transcriptional responsiveness to PRV during early
PRV amplification was recently reported by Johansen et
al. [57] who challenged Atlantic salmon parr and smolts
with PRV through cohabitation in freshwater and sea-
water, respectively, using PRV source material from an
outbreak of HSMI. The challenge resulted in heart le-
sions typical of HSMI in both life history stages at
8 weeks post cohabitation and many antiviral responsive
genes were shown to be unregulated in kidney and
spleen by microarray analysis during early PRV infection
(particularly in parr) for which some genes were con-
firmed to be significantly elevated by qPCR. However,
both microarray and qPCR analysis identified significant
induction of antiviral genes at 4 wpc even though PRV
transcripts were not detected by qPCR until 6 wpc,
which makes the relationship of their expression in ref-
erence to PRV very difficult to interpret.
Why Sockeye salmon infected with PRV have such a
limited transcriptional response in the presence of in-
creasing viral loads is unclear; however, many reoviruses
are known to use blood as a means for disseminating
from a port of entry to target tissues and leukocytes,
erythrocytes and platelets have all been shown to be sus-
ceptible to at least one form of reoviral infection in a
wide range of host organisms (reviewed by [58]). Never-
theless, the presence of reovirus in blood is not usually
associated with anemia or leukopenia, and to our know-
ledge reoviruses have not been shown to induce antiviral
responses in vivo directly from blood cells due to infec-
tion. In our current study we did not observe anemia
due to the presence of PRV (Additional file 4) which has
also been noted previously in other non-pathogenic PRV
infections of Atlantic and Pacific salmon [13, 17] as well
as during infections associated with HSMI [7, 11]. In
contrast, dissemination of many pathogenic orthoreo-
viruses into target tissues quickly leads to host immune
responses and pathology. For example, induction of host
immune responses leading to cellular apoptosis is con-
sidered the major cause for mammalian reovirus (MRV)
encephalitis and myocarditis, which appears to be initi-
ated shortly after viral cell entry and before the core par-
ticles become transcriptionally active in these target cells
[59, 60]. Thus, the general lack of cellular responses and
apoptosis signalling in blood compared to tissues follow-
ing mammalian reoviral infection is suggestive of a fun-
damental difference in the way blood cells and target
tissue cells interact with this virus. We hypothesize that
PRV also interacts differently with blood cells compared
to tissue cells, and that PRV can evade antiviral re-
sponses during erythrocyte entry and replication in vivo.
Following primary replication in erythrocytes, we sus-
pect the dissemination of virus into resident tissue cells
causes host antiviral responses for which Epd may be in-
volved. Still, erythrocytes have been shown to mount
antiviral responses against PRV ex vivo [11] and further
work will be required to identify a mechanism to explain
the variability for PRV to induce host cell responses dur-
ing natural infection.
Differences in cell and/or tissue type interaction
with PRV also does not explain the presence or ab-
sence of HSMI following PRV infection, as PRV
loads have been observed to reach comparable levels
with or without pathology in both heart and skeletal
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muscle [6, 17]. One potential explanation for this dis-
parity may involve genetic variation between PRV iso-
lates. Siah et al. [3] recently conducted a phylogenetic
analysis of all segments of the PRV obtained from west-
ern North America as well as selected Norwegian and
Chilean PRV genomes. With the exception of segment
S4, samples of North American PRV clustered separ-
ately from the Norwegian and Chilean samples indicat-
ing that there are genetic differences across the genome
between Pacific, Norwegian and Chilean forms of PRV.
In the case of mammalian reoviruses, small changes in
the genome can be reflected in dramatic changes in in-
fectivity and virulence [61, 62]. For example, Doyle et
al. [61] identified that a single amino change in the ơ3
protein, which affects outer capsid stability, was sufficient
to increase replication, host to host spread, and virulence
in mice. Based on the analysis of samples of PRV from
Norway, Wessel et al. [11] determined that the ơ3 protein
had a dsRNA binding function similar to that reported for
the ơ3 protein of mammalian orthoreovirus. The dsRNA-
binding activity of the MRV ơ3 protein inhibits the induc-
tion of type-1 IFN and activation of protein kinase R
(PKR) which through its interaction with translation initi-
ation factor (eIF2α) inhibits cellular mRNA translation,
thereby, limiting viral protein production. Siah et al. [3]
compared the predicted structure of the North American
PRV ơ3 protein to predicted ơ3 proteins based on Norwe-
gian/Chilean sequences. These authors identified an amino
acid difference which results in a predicted change in sec-
ondary structure from an “alpha-helix” in Norwegian/Chil-
ean PRV source to a “sheet structure” in North American
PRV sequences. These authors also identified an amino acid
substitution in the μ1 protein between North American and
Norwegian/Chilean PRV which results in a predicted change
in protein structure. Whether these predicted changes in sec-
ondary structure results in changes of function for these pro-
teins and or virulence differences between these PRV
sources is unknown.
Epigenetic host factors may also provide a possible ex-
planation for regional or stock inconsistency regarding
PRV associated disease. In this study, the majority of
unigenes that were expressed in response to PRV infec-
tion were non-coding. Additional investigation and val-
idation for the putative PRV responsive long non-coding
RNAs (lncRNAs) identified in this study may therefore
prove valuable, as lncRNAs have been shown to play
critical roles in epigenetic transcription silencing [63, 64]
and can have post-translational abilities to alter protein
function in mammals [65]. A number of lncRNAs have
also been speculated to be important during infectious sal-
mon anemia virus (ISAV) infection of Atlantic salmon
[66], although the functions for either PRV-responsive
host lncRNAs identified in this study or ISAV-responsive
lncRNAs identified previously are so far unknown.
Another potential factor for altering virulence during
PRV infection could be the involvement of a coinfecting
pathogen. A number of significant human diseases are
known to be caused or exacerbated as a result of coin-
fections involving viral pathogens [67–71], and infec-
tion by avian reovirus in chickens has been shown to
substantially increase anemia caused by chicken anemia
virus during dual infection [72]. Alternatively, a coin-
fecting agent may provide protection against other viral
infection; such as in the increased survival afforded to
chum salmon reovirus (CSV) or infectious pancreatic
necrosis virus (IPNV) infected rainbow trout during le-
thal IHNV superinfection [73, 74]. In this study, PRV
did not protect Sockeye against superinfection IHNV.
This is not entirely surprising, as the induction of
interferon antiviral responses is usually the mechanism
for protection during viral coinfections and is likely re-
sponsible for the previous reports of IHNV protection
in rainbow trout afforded by CSV or IPNV mentioned
above [75]. As PRV had little to no effect on systemic
or kidney specific cellular signalling for the first
3 weeks following exposure which included the first
week (peak load) of IHNV superinfection, a similar
mechanism for protection seems unlikely to be gener-
ated from PRV during this period. Nevertheless, we
hypothesize timing may be critical with regard to this
type of putative protection, and suspect that exposure
to IHNV following peak PRV dissemination which
causes host antiviral activation (in this study, a brief
period starting at 4 wpc) may indeed contribute to a
reduced virulence of IHNV if exposure occurred dur-
ing this time. Further work in identifying such protec-
tion may warrant additional investigation; however any
putative protection would likely be short lived, as anti-
viral responses generated against PRV in this study
abated by 9 wpc in the absence of PRV associated
disease.
Conversely, one of the more surprising observations
of this study was the lack of protection afforded by
host antiviral responses against IHNV to inhibit PRV
transcription and dissemination. PRV transcriptional
loads continued to increase at comparable rates in
both blood and kidney with or without the consider-
able transcriptomic changes induced by IHNV. In a
previous Norwegian study, chronic IPNV infections
also did not significantly alter PRV transcription, nor
was vaccination with bacterial and IPNV antigen
8 weeks before PRV exposure able to reduce PRV loads
at 7 wpc [76]. Collectively, these data suggest that al-
though PRV does not appear to induce a significant
antiviral state during early dissemination, the activa-
tion of host antiviral responses during this time
appears inconsequential to PRV transcription in either
the blood or kidney.
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Conclusions
Here we demonstrate that PRV causes minimal changes to
the Sockeye salmon head kidney transcriptome during the
first 3 weeks of infection following injection. Viral loads
increased substantially during this period in both blood
and kidney tissues which indicate that PRV has the ability
to evade or block host recognition during hematogenous
dissemination and early replication within the Sockeye sal-
mon. In this instance, evasion rather than active blocking
of host responses is more likely, as PRV had no measured
impact on the substantial host transcriptional responses
generated against superinfection with IHNV during this
period.
Robust host transcriptome responses that included
activation of classic antiviral pathways generated during
IHNV superinfection did not affect increases in PRV
transcriptional load. The mechanisms for why antiviral
responses fail to impact PRV transcription, induce
erythrocyte/renal cell apoptosis, or lead to pathology in
Sockeye salmon are still unclear; however we suspect
variations in the way PRV interacts with different cell
types may be important. Here we identified a late in-
crease in Mx expression at 4 wpc during a period of
peak viral loads in kidney tissue which was preceded by
an increased expression of Epd at 3 wpc in PRV in-
fected kidneys but not blood. Although the role of Epd
in PRV infection is currently unknown, its previous as-
sociation with stress/immune functions in other fish
species and its lone transcriptional regulation during
early PRV infection in Sockeye suggests an important
putative role in host PRV responsiveness and warrants
further investigation.
The reason for the very limited transcriptional response
in Sockeye salmon to PRV within the first 3–4 weeks of
infection remains unclear. Although we hypothesize that
disparities in the way PRV interacts with different cell
types may explain some aspects regarding host respon-
siveness to PRV, there are many factors involved in PRV
pathogenesis which make comparisons of current studies
difficult. For example, some transcriptional differences ob-
served in response to PRV can likely be attributed to dif-
ferences in host species (Sockeye vs. Atlantic salmon).
This study also focused on the head kidney which may
have a different transcriptional profile when compared to
heart tissues. It is also possible that genotypic differences
exist between North American PRV and the types of PRV
that are associated with strong transcriptional responses
and the presentation of the HSMI disease state in Norway.
Lastly, the experiment that we are reporting was con-
ducted in a controlled environment with optimal water
conditions. Under these conditions, it appears that PRV is
of low virulence to Sockeye salmon and that carriers of
PRV are not at a disadvantage when it comes to super-
infection with IHNV. Whether these results will hold
under less optimal more stressful conditions such as those
experienced in the field warrant further consideration.
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